Hong Kong Pharmaceuticals and Healthcare Report Q2 2010

Executive Summary ..................................................5
SWOT Analysis..........................................................6
Hong Kong Pharmaceuticals And Healthcare Industry SWOT....................................... 6
Hong Kong Political SWOT............................................................................................ 7
Hong Kong Economic SWOT......................................................................................... 7
Hong Kong Business Environment SWOT ...................................................................... 7
Pharmaceutical Business Environment Ratings ..........................................................................................9
Table: Asia Pacific Pharmaceutical Business Environment Ratings For Q210............... 9
Limits of Potential Returns ........................................................................................... 10
Risks to Realisation of Returns ..................................................................................... 10
Hong Kong – Market Summary...............................12
Regulatory Regime..................................................13
Intellectual Property Issues .......................................................................................... 14
Counterfeit Drugs ................... 15
Pricing and Reimbursement Developments................................................................... 16
Public Procurement of Medicines ................................................................................. 16
Industry Trends and Developments .......................18
Epidemiology.......................... 18
Table: Leading Causes Of Death In Hong Kong, 2001-2008........................................ 19
Recent Public Health Developments ............................................................................. 20
Healthcare Sector ................... 20
Healthcare Sector Reforms ........................................................................................... 21
Healthcare Financing................................................................................................... 22
Recent Developments in Healthcare Financing ............................................................ 23
Pharmaceutical Supply Chain ...................................................................................... 24
Retail Pharmacy Sector ................................................................................................ 25
Biotechnology ......................... 26
Clinical Trials......................... 26
Medical Devices...................... 27
Table: Examples Of Medical Devices in Hong Kong.................................................... 29
Industry Forecast Scenario....................................30
Overall Market Forecast............................................................................................... 30
Key Growth Factors – Industry..................................................................................... 31
Key Growth Factors – Macroeconomic ........................................................................ 32
Hong Kong – Economic Activity ................................................................................... 33
Prescription Drug Market Forecast.............................................................................. 34
Patented Drug Market Forecast ................................................................................... 35
Generic Drug Market Forecast..................................................................................... 36
OTC Market Forecast................................................................................................... 37
Pharmaceutical Trade Forecast ................................................................................... 39
Other Healthcare Indicators......................................................................................... 41
Key Risks to Forecast Scenario.......................................................................... 42
Competitive Landscape..........................................43
Pharmaceutical Industry............................................................................................... 43
Traditional Chinese Medicines ..................................................................................... 44
Foreign Industry Developments.................................................................................... 44
Company Profiles....................................................46
Indigenous Companies................. 46
Wuyi International Pharmaceutical .............................................................................. 46
CK Life Sciences ..................... 48
South Asia Pharmamedic.............................................................................................. 51
C&Y Pharmaceutical Investment.................................................................................. 52
Vida Laboratories................... 53
Multinationals.............................. 54
GlaxoSmithKline..................... 54
Pfizer ...................................... 56
Sanofi-Aventis......................... 58
Merck & Co ............................ 60
Novartis .................................. 61
Country Snapshot: Hong Kong Demographic Data ...................................................................................62
Section 1: Population.............. 62
Table: Demographic Indicators, 2005-2030................................................................. 62
Table: Rural/Urban Breakdown ................................................................................... 63
Section 2: Education And Healthcare........................................................................... 63
Table: Education, 2002-2005 ....................................................................................... 63
Table: Vital Statistics, 2005-2030................................................................................. 63
Section 3: Labour Market And Spending Power ........................................................... 64
Table: Employment Indicators, 2001-2006................................................................... 64
Table: Consumer Expenditure, 2000-2012 (US$) ......................................................... 64
Table: Average Annual Wages, 2005-2012................................................................... 65
Methodology ....................................................66
How We Generate Our Pharmaceutical Industry Forecasts .............................................. 66
Pharmaceutical Business Environment Ratings Methodology ........................................... 67
Ratings Overview.................... 67
Table: Pharmaceutical Business Environment Indicators ............................................ 68
Weighting................................ 69
Table: Weighting Of Components ................................................................................. 69
Sources ........................................ 69
Forecast Tables .......................................................70